Company / Return on Assets (ROA)
Harmony Biosciences Holdings, Inc. Return on Assets (ROA) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
12.5%
FY2025
5-year range
-35.1% / 26.9%
FY2021-FY2025
Trend
-14.3%
vs FY2024
Sector context
#25 of 213
Health Care
What the data says
Harmony Biosciences Holdings, Inc.'s return on assets (roa) of 12.5% is higher than 88% of companies in the Health Care sector (FY2025). Return on Assets (ROA) has declined for 3 consecutive years, from 26.9% in FY2022 to 12.5% in FY2025.
Based on SEC 10-K filings.
12.5% in FY2025 with a 5-year CAGR of +48.1%. Top quartile in the Health Care sector.
Declined from 15.9% to 12.5% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -14.4pp
- 5-Year Change
- +48.1pp
- 10-Year Change
- -
Sector benchmark
+151.6% above sector average
Key checks
Key Insights
- Harmony Biosciences Holdings, Inc.'s return on assets (roa) has declined for 3 consecutive years.
- In FY2025, return on assets (roa) decreased 14.3% year-over-year.
- Currently 36.6pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2022.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 12.5% | -14.3% |
| FY2024 | 14.6% | -8.3% |
| FY2023 | 15.9% | -41.0% |
| FY2022 | 26.9% | +176.8% |
| FY2021 | -35.1% | +1.5% |
| FY2020 | -35.6% | +75.0% |
| FY2019 | -142.4% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026